MAPT and supranuclear palsy, progressive, 1: Further investigations are anticipated for elucidating the tracers binding with cryo-EM structures of tau filaments from CBD and PSP and for rational designing of disease (strain) specific to develop tracers with an increased specificity and binding activity (Fitzpatrick et al., 2017; Zhang et al., 2020).